Acutus Medical (NASDAQ:AFIB) Upgraded to Hold at Zacks Investment Research

Acutus Medical (NASDAQ:AFIB – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Acutus Medical Inc. is an arrhythmia management company. It focused on the way cardiac arrhythmias are diagnosed and treated. Acutus Medical Inc. is […]

Related Keywords

California ,United States ,William Blair ,Acutus Medical Inc ,Goldman Sachs Group Inc ,Zacks Investment Research ,Millennium Management ,Parametric Portfolio Associates ,Capital Partners ,Acutus Medical ,Get Rating ,Sachs Group ,Portfolio Associates ,Nasdaq Afib ,Afib ,Medical ,Upgrade ,